- Home
- OTLK vs MODD Comparison
OTLK vs MODD Comparison
Compare OTLK & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- MODD
- Stock Information
- Founded
- OTLK 2010
- MODD 1998
- Country
- OTLK United States
- MODD United States
- Employees
- OTLK N/A
- MODD N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- MODD Industrial Specialties
- Sector
- OTLK Health Care
- MODD Health Care
- Exchange
- OTLK Nasdaq
- MODD Nasdaq
- Market Cap
- OTLK 48.3M
- MODD 46.3M
- IPO Year
- OTLK 2016
- MODD N/A
- Fundamental
- Price
- OTLK $2.34
- MODD $0.72
- Analyst Decision
- OTLK Strong Buy
- MODD
- Analyst Count
- OTLK 5
- MODD 0
- Target Price
- OTLK $9.60
- MODD N/A
- AVG Volume (30 Days)
- OTLK 1.1M
- MODD 79.3K
- Earning Date
- OTLK 08-14-2025
- MODD 08-14-2025
- Dividend Yield
- OTLK N/A
- MODD N/A
- EPS Growth
- OTLK N/A
- MODD N/A
- EPS
- OTLK N/A
- MODD N/A
- Revenue
- OTLK $1,505,322.00
- MODD N/A
- Revenue This Year
- OTLK N/A
- MODD N/A
- Revenue Next Year
- OTLK $407.74
- MODD N/A
- P/E Ratio
- OTLK N/A
- MODD N/A
- Revenue Growth
- OTLK N/A
- MODD N/A
- 52 Week Low
- OTLK $0.87
- MODD $0.63
- 52 Week High
- OTLK $8.32
- MODD $2.65
- Technical
- Relative Strength Index (RSI)
- OTLK 63.83
- MODD 48.03
- Support Level
- OTLK $1.95
- MODD $0.70
- Resistance Level
- OTLK $2.14
- MODD $0.76
- Average True Range (ATR)
- OTLK 0.17
- MODD 0.04
- MACD
- OTLK 0.03
- MODD 0.00
- Stochastic Oscillator
- OTLK 77.62
- MODD 38.35
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.